Preventive Healthcare Technologies And Services Market By Type (vaccines, Chronic Disease Management Technologies, Advanced Technologies To Reduce Errors And Early Detection And Screening Technologies) - Global Industry Analysis And Forecast To 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Preventive Healthcare Technologies and Services Market, By Type

5.1.       Introduction

5.2.       Global Preventive Healthcare Technologies and Services Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Preventive Healthcare Technologies and Services Revenue and Revenue Share by Type (2017-2027)

5.3.       Vaccines

5.3.1.  Global Vaccines Revenue and Growth Rate (2017-2027)

5.3.2.  Global Vaccines Revenue and Growth Rate By Type (2017-2027)

5.3.3.  Infectious Diseases Vaccine

5.3.3.1.    Global Infectious Diseases Vaccine Revenue and Growth Rate (2017-2027)

5.3.4.  Allergy Vaccine

5.3.4.1.    Global Allergy Vaccine Revenue and Growth Rate (2017-2027)

5.3.5.  Cancer Vaccine

5.3.5.1.    Global Cancer Vaccine Revenue and Growth Rate (2017-2027)

5.3.6.  Autism Vaccine

5.3.6.1.    Global Autism Vaccine Revenue and Growth Rate (2017-2027)

5.3.7.  Other Vaccines

5.3.7.1.    Global Other Vaccines Revenue and Growth Rate (2017-2027)

5.4.       Chronic Disease Management Technologies

5.4.1.  Global Chronic Disease Management Technologies Revenue and Growth Rate (2017-2027)

5.4.2.  Global Chronic Disease Management Technologies Revenue and Growth Rate By Type (2017-2027)

5.4.3.  Blood Pressure Monitors

5.4.3.1.    Global Other Blood Pressure Monitors Revenue and Growth Rate (2017-2027)

5.4.4.  Glucose Monitors

5.4.4.1.    Global Glucose Monitors Revenue and Growth Rate (2017-2027)

5.4.5.  Cardiovascular Monitors

5.4.5.1.    Global Cardiovascular Monitors Revenue and Growth Rate (2017-2027)

5.4.6.  Asthma Monitors

5.4.6.1.    Global Asthma Monitors Revenue and Growth Rate (2017-2027)

5.5.       Advanced Technologies to Reduce Errors

5.5.1.  Global Advanced Technologies to Reduce Errors Revenue and Growth Rate (2017-2027)

5.5.2.  Global Advanced Technologies to Reduce Errors Revenue and Growth Rate By Type (2017-2027)

5.5.3.  Electronic Prescribing

5.5.3.1.    Global Electronic Prescribing Revenue and Growth Rate (2017-2027)

5.5.4.  Smart Infusion Pumps

5.5.4.1.    Global Smart Infusion Pumps Revenue and Growth Rate (2017-2027)

5.5.5.  Clinical Decision Supports System

5.5.5.1.    Global Clinical Decision Supports System Revenue and Growth Rate (2017-2027)

5.5.6.  Smart Packaging and Automated Prescription Formulation and Dispensing

5.5.6.1.    Global Smart Packaging and Automated Prescription Formulation and Dispensing Revenue and Growth Rate (2017-2027)

5.5.7.  Computerized Provider Order Entry System

5.5.7.1.    Global Computerized Provider Order Entry System Revenue and Growth Rate (2017-2027)

5.6.       Early Detection and Screening Technologies

5.6.1.  Global Early Detection and Screening Technologies Revenue and Growth Rate (2017-2027)

5.6.2.  Global Early Detection and Screening Technologies Revenue and Growth Rate By Type (2017-2027)

5.6.3.  Automated Screening

5.6.3.1.    Global Automated Screening Revenue and Growth Rate (2017-2027)

5.6.4.  Personalized Medicine

5.6.4.1.    Global Personalized Medicine Revenue and Growth Rate (2017-2027)

5.6.5.  Other Screening Technologies

5.6.5.1.    Global Other Screening Technologies Revenue and Growth Rate (2017-2027)

6.       Preventive Healthcare Technologies and Services Market, By Region

6.1.       Introduction

6.2.       Global Preventive Healthcare Technologies and Services Revenue and Market Share by Regions

6.2.1.  Global Preventive Healthcare Technologies and Services Revenue by Regions (2017-2027)

6.3.       North America Preventive Healthcare Technologies and Services by Countries

6.3.1.  North America Preventive Healthcare Technologies and Services Revenue and Growth Rate (2017-2027)

6.3.2.  North America Preventive Healthcare Technologies and Services Revenue by Countries (2017-2027)

6.3.3.  North America Preventive Healthcare Technologies and Services Revenue (Million USD) by Countries (2017-2027)

6.3.4.  U.S.

6.3.4.1.    United States Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Canada

6.3.5.1.    Canada Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.6.  Mexico

6.3.6.1.    Mexico Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.       Europe Preventive Healthcare Technologies and Services by Countries

6.4.1.  Europe Preventive Healthcare Technologies and Services Revenue and Growth Rate (2017-2027)

6.4.2.  Europe Preventive Healthcare Technologies and Services Revenue by Countries (2017-2027)

6.4.3.  Europe Preventive Healthcare Technologies and Services Revenue (Million USD) by Countries (2017-2027)

6.4.4.  Germany

6.4.4.1.    Germany Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.    UK Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  France

6.4.6.1.    France Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Russia

6.4.7.1.    Russia Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Italy

6.4.8.1.    Italy Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.9.  Rest of Europe

6.4.9.1.    Rest of Europe Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.       Asia-Pacific

6.5.1.  Asia-Pacific Preventive Healthcare Technologies and Services Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific Preventive Healthcare Technologies and Services Revenue by Countries (2017-2027)

6.5.3.  Asia-Pacific Preventive Healthcare Technologies and Services Revenue (Million USD) by Countries (2017-2027)

6.5.4.  China

6.5.4.1.    China Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Japan

6.5.5.1.    Japan Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.2.     

6.5.6.  Korea

6.5.6.1.    Korea Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  India

6.5.7.1.    India Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Southeast Asia

6.5.8.1.    Southeast Asia Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.9.  Rest of Asia-Pacific

6.5.9.1.    Rest of Asia-Pacific Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.       South America

6.6.1.  South America Preventive Healthcare Technologies and Services Revenue and Growth Rate (2017-2027)

6.6.2.  South America Preventive Healthcare Technologies and Services Revenue by Countries (2017-2027)

6.6.3.  South America Preventive Healthcare Technologies and Services Revenue (Million USD) by Countries (2017-2027)

6.6.4.  Brazil

6.6.4.1.    Brazil Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Argentina

6.6.5.1.    Argentina Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Columbia

6.6.6.1.    Columbia Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.7.  Rest of South America

6.6.7.1.    Rest of South America Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.       Middle East and Africa

6.7.1.  Middle East and Africa Preventive Healthcare Technologies and Services Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa Preventive Healthcare Technologies and Services Revenue by Countries (2017-2027)

6.7.3.  Middle East and Africa Preventive Healthcare Technologies and Services Revenue (Million USD) by Countries (2017-2027)

6.7.4.  Saudi Arabia

6.7.4.1.    Saudi Arabia Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  United Arab Emirates

6.7.5.1.    United Arab Emirates Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Egypt

6.7.6.1.    Egypt Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  Nigeria

6.7.7.1.    Nigeria Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  South Africa

6.7.8.1.    South Africa Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.    Rest of Middle East and Africa Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.       ScriptPro LLC

7.1.1.  Business Overview

7.1.2.  Type Portfolio

7.1.3.  Strategic Developments

7.1.4.  Revenue and Market Share

7.2.       Omnicell, Inc.

7.2.1.  Business Overview

7.2.2.  Type Portfolio

7.2.3.  Strategic Developments

7.2.4.  Revenue and Market Share

7.3.       LIFECOM, Inc.

7.3.1.  Business Overview

7.3.2.  Type Portfolio

7.3.3.  Strategic Developments

7.3.4.  Revenue and Market Share

7.4.       Myriad Genetics, Inc.

7.4.1.  Business Overview

7.4.2.  Type Portfolio

7.4.3.  Strategic Developments

7.4.4.  Revenue and Market Share

7.5.       Dilon Technologies, Inc.

7.5.1.  Business Overview

7.5.2.  Type Portfolio

7.5.3.  Strategic Developments

7.5.4.  Revenue and Market Share

7.6.       NOVX Systems Inc.

7.6.1.  Business Overview

7.6.2.  Type Portfolio

7.6.3.  Strategic Developments

7.6.4.  Revenue and Market Share

7.7.       Medtronic plc

7.7.1.  Business Overview

7.7.2.  Type Portfolio

7.7.3.  Strategic Developments

7.7.4.  Revenue and Market Share

7.8.       Omron Healthcare, Inc.

7.8.1.  Business Overview

7.8.2.  Type Portfolio

7.8.3.  Strategic Developments

7.8.4.  Revenue and Market Share

7.9.       Sanofi

7.9.1.  Business Overview

7.9.2.  Type Portfolio

7.9.3.  Strategic Developments

7.9.4.  Revenue and Market Share

7.10.    Merck & Co., Inc.

7.10.1.      Business Overview

7.10.2.      Type Portfolio

7.10.3.      Strategic Developments

7.10.4.      Revenue and Market Share

8.       Global Preventive Healthcare Technologies and Services Market Competition, by Manufacturer

8.1.       Global Preventive Healthcare Technologies and Services Revenue and Market Share by Manufacturer (2017-2017)

8.2.       Global Preventive Healthcare Technologies and Services Price by Region (2017-2017)

8.3.       Top 5 Preventive Healthcare Technologies and Services Manufacturer Market Share

8.4.       Market Competition Trend

9.       Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.1.       Global Preventive Healthcare Technologies and Services Revenue (Millions USD) and Growth Rate (2027-2023)

9.2.       Preventive Healthcare Technologies and Services Market Forecast by Regions (2027-2023)

9.2.1.  North America Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.1.1.    United States Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.1.2.    Canada Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.1.3.    Mexico Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.  Europe Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.1.    Germany Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.2.    United Kingdom Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.3.    France Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.4.    Russia Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.5.    Italy Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.2.6.    Rest of the Europe Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.  Asia-Pacific Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.1.    China Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.2.    Japan Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.3.    Korea Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.4.    India Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.5.    Southeast Asia Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.3.6.    Rest of Asia-Pacific Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.4.  South America Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.4.1.    Brazil Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.4.2.    Argentina Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.4.3.    Columbia Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.4.4.    Rest of South America Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.  Middle East and Africa Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.1.    Saudi Arabia Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.2.    UAE Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.3.    Egypt Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.4.    Nigeria Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.5.    South Africa Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.2.5.6.    Rest of MEA Preventive Healthcare Technologies and Services Market Forecast (2027-2023)

9.3.       Preventive Healthcare Technologies and Services Market Forecast by Type (2027-2023)

9.3.1.  Global Preventive Healthcare Technologies and Services Revenue Forecast by Type (2027-2023)

9.3.2.  Global Preventive Healthcare Technologies and Services Revenue Market Share Forecast by Type (2027-2023)

9.4.       Preventive Healthcare Technologies and Services Market Forecast by Application (2027-2023)

9.4.1.  Global Preventive Healthcare Technologies and Services Revenue Forecast by Application (2027-2023)

9.4.2.  Global Preventive Healthcare Technologies and Services Revenue Market Share Forecast by Application (2027-2023)

9.5.       Preventive Healthcare Technologies and Services Market Forecast by Technology (2027-2023)

9.5.1.  Global Preventive Healthcare Technologies and Services Revenue Forecast by Technology (2027-2023)

9.5.2.  Global Preventive Healthcare Technologies and Services Revenue Market Share Forecast by Technology (2027-2023)

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Preventive Healthcare Technologies and Services Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country